VETS Co-Founder & CEO Amber Capone Named to Inc.'s 2026 Female Founders 500 List for Second Consecutive Year

Amber Capone, co-founder and CEO of VETS, has been named to Inc.’s 2026 Female Founders 500 List for the second consecutive year, recognizing her leadership in advancing research, policy reform, and expanded access to psychedelic-assisted therapies for veterans.

New Jersey Governor Signs Psilocybin Therapy Bill Into Law, Advancing Evidence-Based Treatment Options for Mental Health

This groundbreaking initiative will enable psilocybin-assisted therapy trials at three hospitals across the state. VETS played a pivotal role in advancing this legislation.

Press Release: Eliza Dushku, Mental Health Counselor and Former Actress, Joins VETS Board of Directors

VETS welcomes former actress and clinical mental health specialist Eliza Dushku to its Board of Directors, bringing her expertise in psychedelic-assisted therapy and unwavering commitment to veteran mental health to further VETS’ mission of ending the veteran suicide epidemic.

California Governor Newsom Signs AB 1103 to Accelerate Psychedelic Research for Veterans and Mental Health Innovation

Legislation sponsored by VETS will expedite critical research on psychedelic therapies for PTSD, traumatic brain injury, and substance use disorders in California

JOIN US

Your involvement could help save a life. Thank you for joining us in this crucial fight for our nation's veterans.
Stay in the loop, sign up for updates: